R. Yokoyama

Interpretations of SARS-CoV-2 IgM and IgG antibody titers in the seroepidemiological study of asymptomatic healthy volunteers

M. Kurano, Y. Yatomi, T. Horie, 2021, Journal of Infection and Chemotherapy.

Time course of the sensitivity and specificity of serum anti-SARS-CoV-2 IgM and IgG antibodies for the diagnosis of symptomatic COVID-19 in Japan

Y. Seto, M. Kurano, Y. Yatomi, 2020 .

Association of the Serum Levels of the Nucleocapsid Antigen of SARS-CoV-2 With the Diagnosis, Disease Severity, and Antibody Titers in Patients With COVID-19: A Retrospective Cross-Sectional Study

Hiroko Ohmiya, M. Kurano, Y. Yatomi, 2021, Frontiers in Microbiology.

Measurement of SARS-CoV-2 Antibody Titers Improves the Prediction Accuracy of COVID-19 Maximum Severity by Machine Learning in Non-Vaccinated Patients

Hiroko Ohmiya, M. Kurano, Y. Yatomi, 2022, Frontiers in Immunology.

Time course of the sensitivity and specificity of anti-SARS-CoV-2 IgM and IgG antibodies for symptomatic COVID-19 in Japan

Y. Seto, M. Kurano, Y. Yatomi, 2021, Scientific Reports.

Response kinetics of different classes of antibodies to SARS-CoV2 infection in the Japanese population: The IgA and IgG titers increased earlier than the IgM titers

Hiroko Ohmiya, M. Kohara, M. Kurano, 2021, International Immunopharmacology.

Validation of a new automated chemiluminescent anti-SARS-CoV-2 IgM and IgG antibody assay system detecting both N and S proteins in Japan

Y. Seto, M. Kurano, Y. Yatomi, 2020, medRxiv.